Skip to main content
2024 Canadian Cardiovascular Congress Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Handout
Handout
Networking
Networking
On-Demand
On-Demand
Early Career Involvement
Early Career Involvement
Back
Session Evaluation

CORONARY ARTERY DISEASE - GENERAL

IMAGING

EDUCATION

INTERVENTIONAL

EARLY CAREER INVOLVEMENT

CAIC

235 - CORONARY MICROVASCULAR DYSFUNCTION: A TEAM BASED APPROACH

Friday, October 25, 2024
11:00 AM – 12:00 PM PT
Room: 212-213
Early Career Involvement
Workshop Description: Coronary microvascular dysfunction is an increasingly better recognized clinical entity that is often variably diagnosed and inconsistently treated. Given the frequency of patients with angina in the absence of obstructive CAD, collective diagnostic frameworks are evolving to appreciate the nature of the coronary circulation as a dynamic network with delicate coronary vasomotor regulation. There is, however, still great heterogeneity with respect to diagnostic terminology with gaps in the literature regarding the diagnosis and management of CMD. CMD care worldwide is in its nascent stages. Across Canada, there are pockets of individual expertise but no comprehensive interdisciplinary programs for CMD care. This workshop aims to collect these clusters of individual expertise in CMD and will provide a forum that facilitates the sharing of best practices with the aim of informing the development of interdisciplinary systems of care for this vulnerable patient population.

There has been an emerging consensus on the invasive and non-invasive assessment of CMD, but institutional implementation of these diagnostic pathways continues to remain a step behind the scientific evidence. The care of patients with CMD necessitates well-defined and structured clinical programs with access to non-invasive and invasive assessment modalities. Accordingly, a team of well-coordinated clinical Cardiology, cardiac imaging, and Interventional Cardiology specialists must work in concert to provide care to this unique patient population. Few centers in Canada have well developed programs to meet the needs of these patients. The purpose of this workshop is to guide clinicians in identifying patients with CMD and help provide perspective on how to develop clinical pathways of care, and non-invasive and invasive assessment diagnostic programs to help facilitate the care of patients with CMD.

During this workshop, clinical, interventional, and imaging Cardiology experts in CMD care in Canada will present their institutional processes to care for these patients. These sessions will be interactive with questions to stimulate discussion and will be followed by a Q&A period. We hope that this workshop leads to greater collaboration across Canada with a national consensus on how to develop effect interdisciplinary programs of CMD care to better serve this patient population.

Interactive and Engagement Activities Description: Each presenter will have interactive questions for the audience throughout their presentations. There will be a question and answer period at the end of the of the three presentations and also at the end of the workshop.

Learning Objectives:

At the end of this session participants will be able to:
  • identify and treat patients with coronary microvascular dysfunction;
  • outline the diagnostic work-flow of assessing patients with coronary microvascular dysfunction; and
  • describe how to set-up and implement a diagnostic program (invasive and non-invasive) to assess patients with coronary microvascular dysfunction.
Disclosure(s):
Zeeshan Ahmed, MD, MHPE, FRCPC, DRCPSC: No financial relationships to disclose
Aun-Yeong Chong, MBBS, MD, MRCP: No financial relationships to disclose
John Blair: Abbott: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Philips: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, August 31, 2023)
Kevin Boczar Boczar, MD, FRCPC: MedTrace: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novo Nordisk: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Laurie-Anne Boivin-Proulx, MD MSc: No financial relationships to disclose
Maria Lopez Laporte, MD: No financial relationships to disclose
Tara L. Sedlak, MD, FRCPC: Amgen: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Speaker/Honoraria (Ongoing); BI Lilly: Honoraria for talks and ad boards (Ongoing); HLS: Honoraria for talks and ad boards (Ongoing); KYE Pharmaceuticals: Honoraria for talks and ad boards (Ongoing); Norvartis: Honoraria for talks and ad boards (Ongoing); Novo Nordisk: Honoraria for talks and ad boards (Ongoing); Pfizer: Honoraria for talks and ad boards (Ongoing); Sanofi: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)